ArticleProstate cancer and prostatic diseases2022

Clinical use of the mRNA urinary biomarker SelectMDx test for prostate cancer.

Wieke C H Visser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.